logo

  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Cell Isolation or Cell Separation Market, By Product (Instruments, Flow Cytometers, Centrifuges, Filtration System, Consumables), By Technology (Centrifugation, Filtration, Surface Marker) opportunities and forecast 2020-2027

  • DLR2065
  • 19 September, 2020
  • Automobile & Transportation
  • Pages: 120
  • Global
Market Overview

Growing interest of biotechnology firms and scientists in stem and cancer cell research is major factor boosting growth of market. Progressive cell isolation products provide improved isolation of biological molecules comprising proteins, chromatin, nucleic acids, and protein developments for subsequent analysis. Therefore, the demand for the products is rising, which is anticipated to support cell isolation market growth over the forecast period.

Additionally increasing demand for the personalized medicine is other major factor driving the growth. Personalized medicine is type of medical analysis in which treatment is customized for individual patient. The cell isolation methods can be used in personalized medicine for the early discovery of disease, selection of suitable treatment, and defining the prognosis of therapy.

Segment Overview

On basis of product, market is segmented into instruments and consumables. In 2019, consumables segment was largest revenue share segment. Growing investment in R&D by biopharmaceutical and biotechnology companies is key factor boosting segment growth. Therefore, the demand for the cell separation consumables is anticipated to remain high over the forecast period.

The human type cell isolation is reported to have major share of cell isolation market in 2019. The rising focus on human and cancer stem cell research; and the wide application of seperated human cells in research, clinical trials and biopharmaceuticals development, are major factors contributing to its highest share.

Regional Overview

North America dominated cell isolation market globally in 2019. The well-built research infrastructure and presence of global biotechnology firms in North America have fuelled the regional market. Furthermore, the presence of innovative technology and the large focus on the drug discovery in the region drives sector growth.

Asia Pacific is anticipated to showcase highest growth during forecast period owing to rising presence of the clinical research organizations and the biopharmaceutical companies in the region. The obtainability of vast genome pool, less severe regulations for the drug development, and the availability of experienced personnel in the region are some of major factors accountable for the growth of sector in this region.

Competitor overview

Some of the important players in market are STEMCELL Technologies Inc.; Thermo Fisher Scientific, Inc.; BD Biosciences; Beckman Coulter, Inc.; Merck KGaA; Terumo BCT; Bio-Rad Laboratories, Inc. and GE Healthcare. The major corporations are undertaking numerous strategic initiatives, such as mergers & acquisitions, collaborations, regional expansion and new product launch, for serving unmet needs of their customers.
New product growth helps vendors to increase their product portfolio and to gain maximum market share in sector. For instance, the company, Thermo Scientific’s Medifuge is benchtop centrifuge that is introduced with unique hybrid rotor and also has substitutable swing-out buckets and the fixed-angle rotors to ease rapid and convenient applications on single platform.

Key Players
  1. Thermo Fisher Scientific, Inc.;
  2. Merck KGaA;
  3. BD Biosciences;
  4. Beckman Coulter, Inc.;
  5. Terumo BCT;
  6. GE Healthcare;
  7. STEMCELL Technologies Inc.;
  8. Bio-Rad Laboratories, Inc.

Market Segmentation

By Product
  • Instruments
  • Centrifuges
  • Consumables
  • Flow cytometers
  • Magnetic-activated cell separator systems
  • Filtration systems
By Technology
  • Centrifugation
  • Filtration
  • Surface marker
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 15

    2 Executive Summary 17

      3 Market Introduction 19

      • 3.1 Definition 20
      • 3.2 Scope of the Study 20
      • 3.3 List of Assumptions 20
      • 3.4 Market Structure 21

      4 Research Methodology 22

      • 4.1 Research Process 23
      • 4.2 Primary Research 24
      • 4.3 Secondary Research 25
      • 4.4 Market Size Estimation 26
      • 4.5 Forecast Model 26

      5 Market Dynamics 27

      • 5.1 Introduction 28
      • 5.2 Drivers 29
        • 5.2.1 Rising Government Funding for Cell-Based Research 29
        • 5.2.2 Increasing prevalence of Cancer and Infectious Diseases 29
        • 5.2.3 Growing Technological Advancements in cell isolation devices 29
        • 5.2.4 Growing demand for Personalized Medicine 29
      • 5.3 Restraints 30
        • 5.3.1 High Cost of Cell Isolation Systems 30
        • 5.3.2 Ethical Issues in Stem Cell Isolation 30
      • 5.4 Opportunities 30
        • 5.4.1 Growing Stem Cell Research 30
        • 5.4.2 Application of cell isolation in microfluidics 30
      • 5.5 Challenges 30
        • 5.5.1 Overcoming Limitations of the available cell isolation technologies 30

      6 Market Factor Analysis 31

      • 6.1 Porter’s Five Forces Model 32
        • 6.1.1 Bargaining Power of Suppliers 32
        • 6.1.2 Bargaining Power of Buyers 33
        • 6.1.3 Threat of New Entrants 33
        • 6.1.4 Threat of Substitutes 33
        • 6.1.5 Intensity of Rivalry 33
      • 6.2 Value Chain Analysis 34
        • 6.2.1 R&D and Designing 34
        • 6.2.2 Manufacturing 34
        • 6.2.3 Distribution & Sales 34
        • 6.2.4 Post-Sales Services 34

      7 Global Cell Isolation Market, by Product 35

      • 7.1 Overview 36
      • 7.2 Consumables 37
        • 7.2.1 Reagents, Kits, Media, and Sera 37
        • 7.2.2 Beads 37
        • 7.2.3 Disposables 38
      • 7.3 Instruments 38
        • 7.3.1 Centrifuges 38
        • 7.3.2 Flow Cytometers 39
        • 7.3.3 Magnetic-Activated Cell Separator Systems 39
        • 7.3.4 Filtration Systems 39

      8 Global Cell Isolation Market, by Cell Type 40

      • 8.1 Overview 41
      • 8.2 Human Cells 42
      • 8.3 Animal Cells 42

      9 Global Cell Isolation Market, by Technique 43

      • 9.1 Overview 44
      • 9.2 Centrifugation-Based Cell Isolation 45
      • 9.3 Surface Marker-Based Cell Isolation 45
      • 9.4 Filtration-Based Cell Isolation 46

      10 Global Cell Isolation Market, by Application 47

      • 10.1 Overview 48
      • 10.2 Biomolecule Isolation 49
      • 10.3 Cancer Research 49
      • 10.4 Stem Cell Research 50
      • 10.5 Tissue Regeneration 50
      • 10.6 In Vitro Diagnostics 50
      • 10.7 Therapeutics 51

      11 Global Cell Isolation Market, by End User 52

      • 11.1 Overview 53
      • 11.2 Research Laboratories and Institutes 54
      • 11.3 Biotechnology and Biopharmaceutical Companies 54
      • 11.4 Cell Banks 54
      • 11.5 Hospitals and Diagnostic Laboratories 55

      12 Global Cell Isolation Market, by Region 56

      • 12.1 Overview 57
      • 12.2 Americas 58
        • 12.2.1 North America 61
          • 12.2.1.1 U.S. 64
          • 12.2.1.2 Canada 66
        • 12.2.2 South America 69
      • 12.3 Europe 72
        • 12.3.1 Western Europe 75
          • 12.3.1.1 Germany 78
          • 12.3.1.2 France 80
          • 12.3.1.3 U.K. 83
          • 12.3.1.4 Italy 85
          • 12.3.1.5 Spain 88
          • 12.3.1.6 Rest of Western Europe 90
        • 12.3.2 Eastern Europe 93
      • 12.4 Asia Pacific 96
        • 12.4.1 Japan 99
        • 12.4.2 China 101
        • 12.4.3 India 104
        • 12.4.4 Australia 106
        • 12.4.5 Republic of Korea 109
        • 12.4.6 Rest of Asia Pacific 111
      • 12.5 The Middle east and Africa 114
        • 12.5.1 Middle East 117
        • 12.5.2 Africa 119

      13 Competitive Landscape 122

      • 13.1 Introduction 123
      • 13.2 Company Share Analysis 123

      14 Company Profiles 124

      • 14.1 GE HEALTHCARE 125
        • 14.1.1 Company Overview 125
        • 14.1.2 Financial Overview 125
        • 14.1.3 Products Offering 126
        • 14.1.4 Key Developments 126
        • 14.1.5 SWOT Analysis 126
        • 14.1.6 Key Strategy 126
      • 14.2 STEMCELL Technologies 127
        • 14.2.1 Company Overview 127
        • 14.2.2 Financial Overview 127
        • 14.2.3 Products Offering 127
        • 14.2.4 Key Developments 127
        • 14.2.5 SWOT Analysis 128
        • 14.2.6 Key Strategy 128
      • 14.3 Becton, Dickinson and Company 129
        • 14.3.1 Company Overview 129
        • 14.3.2 Financial Overview 129
        • 14.3.3 Products Offering 130
        • 14.3.4 Key Developments 130
        • 14.3.5 SWOT Analysis 130
        • 14.3.6 Key Strategy 130
      • 14.4 Merck KGaA 131
        • 14.4.1 Company Overview 131
        • 14.4.2 Financial Overview 131
        • 14.4.3 Products Offering 132
        • 14.4.4 Key Developments 132
        • 14.4.5 SWOT Analysis 132
        • 14.4.6 Key Strategy 132
      • 14.5 Thermo Fisher Scientific Inc. 133
        • 14.5.1 Company Overview 133
        • 14.5.2 Financial Overview 133
        • 14.5.3 Products Offering 134
        • 14.5.4 Key Developments 134
        • 14.5.5 SWOT Analysis 134
        • 14.5.6 Key Strategy 134
      • 14.6 Bio-Rad Laboratories Inc 135
        • 14.6.1 Company Overview 135
        • 14.6.2 Financial Overview 135
        • 14.6.3 Products Offering 136
        • 14.6.4 Key Developments 136
        • 14.6.5 SWOT Analysis 136
        • 14.6.6 Key Strategy 136
      • 14.7 TERUMO CORPORATION 137
        • 14.7.2 Financial Overview 137
        • 14.7.3 Products Offering 138
        • 14.7.4 Key Developments 138
        • 14.7.5 SWOT Analysis 138
        • 14.7.6 Key Strategy 138
      • 14.8 Beckman Coulter 139
        • 14.8.1 Company Overview 139
        • 14.8.2 Financial Overview 139
        • 14.8.3 Products Offering 140
        • 14.8.4 Key Developments 140
        • 14.8.5 SWOT Analysis 140
        • 14.8.6 Key Strategy 140
      • 14.9 PluriSelect Life Science UG 141
        • 14.9.1 Company Overview 141
        • 14.9.2 Financial Overview 141
        • 14.9.3 Products Offering 141
        • 14.9.4 Key Developments 141
        • 14.9.5 SWOT Analysis 142
        • 14.9.6 Key Strategy 142
      • 14.10 F. Hoffmann-La Roche AG 143
        • 14.10.1 Company Overview 143
        • 14.10.2 Financial Overview 143
        • 14.10.3 Products Offering 144
        • 14.10.4 Key Developments 144
        • 14.10.5 SWOT Analysis 144
        • 14.10.6 Key Strategy 144
      • 14.11 Miltenyi Biotec 145
        • 14.11.1 Company Overview 145
        • 14.11.2 Financial Overview 145
        • 14.11.3 Products Offering 145
        • 14.11.4 Key Developments 145
        • 14.11.5 SWOT Analysis 146
        • 14.11.6 Key Strategy 146
      • 14.12 Sartorius AG 147
        • 14.12.2 Financial Overview 147
        • 14.12.3 Products Offering 148
        • 14.12.4 Key Developments 148
        • 14.12.5 SWOT Analysis 148
        • 14.12.6 Key Strategy 148
      • 14.13 Cell Biolabs, Inc. 149
        • 14.13.1 Company Overview 149
        • 14.13.2 Financial Overview 149
        • 14.13.3 Products Offering 149
        • 14.13.4 Key Developments 149
        • 14.13.5 SWOT Analysis 149
        • 14.13.6 Key Strategy 149

      15 Appendix 150

      • 15.1 Discussion Blue Print 151

      Report You Might be Interested

      Keywords